Effect of Hypoxia on Shikonin Biosynthesis of Arnebia euchroma Roots and Its Transcriptome Analysis
Physiologia Plantarum · 2025
DOI: 10.1111/ppl.70591 ↗At a glance
Journal article in Physiologia Plantarum, 2025. Written by Qi Li and 12 co-authors. Institution: State Key Laboratory for Quality Ensurance and Sustainable use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of…. Major MEDLINE topics: Naphthoquinones, Plant Roots, Boraginaceae, Transcriptome. 37 references. Funded by: Fundamental Research Funds for the China Academy of Chinese Medical Science Innovation Fund, Fundamental Research Funds for the Central Public Welfare Research Institutes of China, Jiangxi Science and Technology Innovation Base plan Project-The Introduction of Joint Research and Development Institutions.
Abstract (original language)
Shikonin derivatives from Arnebia euchroma (Royle) Johnst. roots possess significant economic value as pharmaceutical agents, natural dyes, and cosmetic additives. To investigate hypoxia's impact on shikonin biosynthesis and its mechanisms, we subjected A. euchroma roots to hypoxic stress (1% O 2 ). Hypoxic roots remained white with minimal shikonin accumulation. Upon reoxygenation (≈20% O 2 ), rapid shikonin synthesis occurred within 4 h. qRT‐PCR revealed suppressed expression of shikonin pathway genes ( CYP76B74 , CYP76B100 , AePGT , etc.) under hypoxia. Transcriptome analysis of roots at 0 h (hypoxia), 4 h, and 48 h (reoxygenation) showed differential gene enrichment in carbon metabolism, phenylpropanoid biosynthesis, and glycolysis. Aerobic respiration genes were upregulated post‐reoxygenation, while anaerobic respiration genes declined. Critically, genes regulating upstream shikonin pathways (MVA/MEP‐PP) were inhibited under hypoxia. These results demonstrate hypoxia's transcriptional repression of shikonin biosynthesis and identify oxygen‐dependent metabolic switches limiting production. These genes are involved in regulating the upstream MVA/MEP‐PP pathway of shikonin biosynthesis, further confirming the inhibitory effect of hypoxia on shikonin biosynthesis.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- State Key Laboratory for Quality Ensurance and Sustainable use of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.
- Key Laboratory of Traditional Chinese Medicine Biology and Cultivation, Ministry of Agriculture and Rural Affairs, Beijing, China.
- Dexing Research and Training Center of Chinese Medical Sciences, Dexing, China.
- Graduate School of China Academy of Chinese Medical Sciences, Beijing, China.
ORCID profiles: Qi Li, Ruishan Wang, Changzheng Liu, Wenjie Luo, Sheng Wang, Lanping Guo
Funding
- Fundamental Research Funds for the China Academy of Chinese Medical Science Innovation Fund
- Fundamental Research Funds for the Central Public Welfare Research Institutes of China
- Jiangxi Science and Technology Innovation Base plan Project-The Introduction of Joint Research and Development Institutions
- National Natural Science Foundation of China
- Beijing Nova Program
Cite
APA
Li, Q., Shi, L., Wang, R., Liu, C., Zhang, C., Wan, X., Yan, B., Luo, W., Guo, X., Shi, K., Song, J., Wang, S., & Guo, L. (2025). Effect of Hypoxia on Shikonin Biosynthesis of Arnebia euchroma Roots and Its Transcriptome Analysis. Physiologia Plantarum. https://doi.org/10.1111/ppl.70591
Vancouver
Li Q, Shi L, Wang R, Liu C, Zhang C, Wan X, et al. Effect of Hypoxia on Shikonin Biosynthesis of Arnebia euchroma Roots and Its Transcriptome Analysis. Physiologia Plantarum. 2025. doi:10.1111/ppl.70591
BibTeX
@article{Li2025,
author = {Li, Qi and Shi, Linyuan and Wang, Ruishan and Liu, Changzheng and Zhang, Chengcai and Wan, Xiufu and Yan, Binbin and Luo, Wenjie and Guo, Xiuzhi and Shi, Kaixuan and Song, Jun and Wang, Sheng and Guo, Lanping},
title = {Effect of Hypoxia on Shikonin Biosynthesis of Arnebia euchroma Roots and Its Transcriptome Analysis},
journal = {Physiologia Plantarum},
year = {2025},
doi = {10.1111/ppl.70591}
}
EUVIMED